MicroRNA: Important Player in the Pathobiology of Multiple Myeloma

被引:53
作者
Bi, Chonglei [1 ,2 ]
Chng, Wee Joo [1 ,2 ,3 ]
机构
[1] Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117599, Singapore
[2] Yong Loo Lin Sch Med, Singapore 119228, Singapore
[3] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Hematol Oncol, Singapore 119228, Singapore
关键词
GENE-EXPRESSION PROFILES; PLASMA-CELL DYSCRASIAS; MONOCLONAL GAMMOPATHY; MOLECULAR CLASSIFICATION; DOWN-REGULATION; IN-VITRO; EPIGENETIC INACTIVATION; IGH TRANSLOCATIONS; KAPPA-B; UNDETERMINED SIGNIFICANCE;
D O I
10.1155/2014/521586
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Recent studies have revealed a pivotal role played by a class of small, noncoding RNAs, microRNA (miRNA), in multiple myeloma (MM), a plasma cell (PC) malignancy causing significant morbidity and mortality. Deregulated miRNA expression in patient's PCs and plasma has been associated with tumor progression, molecular subtypes, clinical staging, prognosis, and drug response in MM. A number of important oncogenic and tumor suppressor miRNAs have been discovered to regulate important genes and pathways such as p53 and IL6-JAK-STAT signaling. miRNAs may also form complex regulatory circuitry with genetic and epigenetic machineries, the deregulation of which could lead to malignant transformation and progression. The translational potential of miRNAs in the clinic is being increasingly recognized that they could represent novel biomarkers and therapeutic targets. This review comprehensively summarizes current progress in delineating the roles of miRNAs in MM pathobiology and management.
引用
收藏
页数:12
相关论文
共 135 条
[1]
Molecular classification of multiple myeloma:: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations [J].
Agnelli, L ;
Bicciato, S ;
Mattioli, M ;
Fabris, S ;
Intini, D ;
Verdelli, D ;
Baldini, L ;
Morabito, F ;
Callea, V ;
Lombardi, L ;
Neri, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7296-7306
[2]
Plasma cell leukemia [J].
Albarracin, Flavio ;
Fonseca, Rafael .
BLOOD REVIEWS, 2011, 25 (03) :107-112
[3]
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 [J].
Amodio, N. ;
Di Martino, M. T. ;
Foresta, U. ;
Leone, E. ;
Lionetti, M. ;
Leotta, M. ;
Gulla, A. M. ;
Pitari, M. R. ;
Conforti, F. ;
Rossi, M. ;
Agosti, V. ;
Fulciniti, M. ;
Misso, G. ;
Morabito, F. ;
Ferrarini, M. ;
Neri, A. ;
Caraglia, M. ;
Munshi, N. C. ;
Anderson, K. C. ;
Tagliaferri, P. ;
Tassone, P. .
CELL DEATH & DISEASE, 2012, 3 :e436-e436
[4]
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells [J].
Amodio, Nicola ;
Bellizzi, Dina ;
Leotta, Marzia ;
Raimondi, Lavinia ;
Biamonte, Lavinia ;
D'Aquila, Patrizia ;
Di Martino, Maria Teresa ;
Calimeri, Teresa ;
Rossi, Marco ;
Lionetti, Marta ;
Leone, Emanuela ;
Passarino, Giuseppe ;
Neri, Antonino ;
Giordano, Antonio ;
Tagliaferri, Pierosandro ;
Tassone, Pierfrancesco .
CELL CYCLE, 2013, 12 (23) :3650-3662
[5]
Amodio N, 2012, ONCOTARGET, V3, P1246
[6]
Gene Expression Profiles of Tumor Biology Provide a Novel Approach to Prognosis and May Guide the Selection of Therapeutic Targets in Multiple Myeloma [J].
Anguiano, Ariel ;
Tuchman, Sascha A. ;
Acharya, Chaitanya ;
Salter, Kelly ;
Gasparetto, Cristina ;
Zhan, Fenghuang ;
Dhodapkar, Madhav ;
Nevins, Joseph ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. ;
Potti, Anil .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) :4197-4203
[7]
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].
Annunziata, Christina M. ;
Davis, R. Eric ;
Demchenko, Yulia ;
Bellamy, William ;
Gabrea, Ana ;
Zhan, Fenghuang ;
Lenz, Georg ;
Hanamura, Ichiro ;
Wright, George ;
Xiao, Wenming ;
Dave, Sandeep ;
Hurt, Elaine M. ;
Tan, Bruce ;
Zhao, Hong ;
Stephens, Owen ;
Santra, Madhumita ;
Williams, David R. ;
Dang, Lenny ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. ;
Kuehl, W. Michael ;
Staudt, Louis M. .
CANCER CELL, 2007, 12 (02) :115-130
[8]
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential [J].
Ballabio, Erica ;
Mitchell, Tracey ;
van Kester, Marloes S. ;
Taylor, Stephen ;
Dunlop, Heather M. ;
Chi, Jianxiang ;
Tosi, Isabella ;
Vermeer, Maarten H. ;
Tramonti, Daniela ;
Saunders, Nigel J. ;
Boultwood, Jacqueline ;
Wainscoat, James S. ;
Pezzella, Francesco ;
Whittaker, Sean J. ;
Tensen, Cornelius P. ;
Hatton, Christian S. R. ;
Lawrie, Charles H. .
BLOOD, 2010, 116 (07) :1105-1113
[9]
Epigenetic regulation of microRNA expression in colorectal cancer [J].
Bandres, Eva ;
Agirre, Xabier ;
Bitarte, Nerea ;
Ramirez, Natalia ;
Zarate, Ruth ;
Roman-Gomez, Jose ;
Prosper, Felipe ;
Garcia-Foncillas, Jesus .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (11) :2737-2743
[10]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29